Schleuning W D, Sudol M, Reich E
J Biol Chem. 1983 Dec 10;258(23):14106-15.
We report the isolation of a specific protease zymogen from chicken plasma. The purification procedure involves barium citrate precipitation, ammonium sulfate fractionation, removal of plasminogen and plasmin on lysine-Sepharose, followed by anion and cation exchange, and gel permeation chromatography. Based on quantitative radioimmunoassay the zymogen is present in plasma at a concentration of 160 mg/liter, and it is obtained by our procedure in highly purified form with a yield of 1.4%. The single polypeptide chain contains an NH2-terminal alanine residue. The native molecule migrates in sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an apparent molecular weight of 84,000 under reducing conditions. It can be identified as an inactive proenzyme because it has very low amidolytic activity, does not react with the fluorescent active site titrant 4-methyl-lumbelliferyl p-guanidinobenzoate, and does not incorporate radioactive [3H]diisopropylfluorophosphate. It is very susceptible to limited proteolysis which converts it to an active enzyme with trypsin-like specificity. The active enzyme, likewise a single polypeptide chain, migrates as a doublet with apparent molecular weights of 39,000 and 40,000. Its amidolytic activity with synthetic peptide substrates is at least 40-fold higher than that of the proenzyme, it reacts efficiently with 4-methylumbelliferyl p-guanidinobenzoate, and incorporates [3H]diisopropylfluorophosphate while undergoing irreversible inactivation. The enzyme appears to be a reasonably efficient plasminogen activator in zymographic gels, but not in solution. With human high molecular weight kininogen as substrate the enzyme was about 25% as efficient as human plasma kallikrein. It lacks any plasminogen-independent proteolytic activity with other protein substrates, and it hydrolyzes small peptide substrates designed for both human kallikrein and urinary urokinase, respectively. Inhibition studies with peptide chloromethyl ketones indicate enzymatic properties closer to human plasma kallikrein than to the human plasminogen activator urokinase (EC 3.4.21.31). The chicken plasma enzyme and the plasminogen activator from the conditioned media of Rous sarcoma virus-transformed chick embryo fibroblasts treated with tumor promoter are different by criteria of tryptic peptide maps, and amino acid composition and enzymatic specificity. The designations chicken plasma prekallikrein plasminogen proactivator and chicken plasma kallikrein plasminogen activator are proposed for the zymogen and enzyme forms, respectively. Using rabbit antibodies against the proenzyme we developed a solid phase immunoadsorption procedure that allowed us to isolate the protein with an overall yield of 11.4%.
我们报告了从鸡血浆中分离出一种特定的蛋白酶原。纯化过程包括柠檬酸钡沉淀、硫酸铵分级分离、在赖氨酸-琼脂糖上去除纤溶酶原和纤溶酶,随后进行阴离子和阳离子交换以及凝胶渗透色谱。基于定量放射免疫测定,该蛋白酶原在血浆中的浓度为160毫克/升,通过我们的方法以高纯度形式获得,产率为1.4%。单条多肽链含有一个NH2末端丙氨酸残基。在还原条件下,天然分子在十二烷基硫酸钠-聚丙烯酰胺凝胶电泳中迁移,表观分子量为84,000。它可被鉴定为无活性的酶原,因为它具有非常低的酰胺水解活性,不与荧光活性位点滴定剂4-甲基-伞形酮基对胍基苯甲酸反应,也不掺入放射性[3H]二异丙基氟磷酸酯。它极易受到有限的蛋白水解作用,从而转化为具有胰蛋白酶样特异性的活性酶。活性酶同样是单条多肽链,以双峰形式迁移,表观分子量分别为39,000和40,000。其对合成肽底物的酰胺水解活性比酶原至少高40倍,能与4-甲基伞形酮基对胍基苯甲酸有效反应,并在不可逆失活过程中掺入[3H]二异丙基氟磷酸酯。该酶在酶谱凝胶中似乎是一种相当有效的纤溶酶原激活剂,但在溶液中则不然。以人高分子量激肽原为底物时,该酶的效率约为人血浆激肽释放酶的25%。它对其他蛋白质底物缺乏任何不依赖纤溶酶原的蛋白水解活性,并且分别水解针对人激肽释放酶和尿激酶设计的小肽底物。用肽氯甲基酮进行的抑制研究表明,其酶学性质更接近人血浆激肽释放酶而非人纤溶酶原激活剂尿激酶(EC 3.4.21.31)。根据胰蛋白酶肽图、氨基酸组成和酶学特异性标准,鸡血浆酶与经肿瘤启动子处理的劳氏肉瘤病毒转化的鸡胚成纤维细胞条件培养基中的纤溶酶原激活剂不同。分别为酶原和酶形式提出了鸡血浆前激肽释放酶纤溶酶原激活剂和鸡血浆激肽释放酶纤溶酶原激活剂的名称。使用针对该酶原的兔抗体,我们开发了一种固相免疫吸附方法,使我们能够以11.4%的总产率分离该蛋白质。